YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Avalyn Pharma Inc. BOSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN) ("Avalyn" or the "Company"), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of ser…
Avalyn Pharma Inc. In silico modeling predicts robust AP01 distribution in healthy and fibrotic lungs, even in severe disease Patient survey findings suggest that clear communication, transparent discussions of potential benefits and risks…
(RTTNews) - The following biotech stocks reached 52-week highs on August 7, 2026, driven by key catalysts such as positive quarterly reports or upcoming clinical results. Halozyme Therapeutics Inc. (HALO) Halozyme is a biopharmaceutical co…
[Business Stock Exchange Trading Concepts] Rawpixel Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY…
This article first appeared on GuruFocus. Avalyn Pharma delivered a sharp first-day move in its Nasdaq debut, with shares jumping 44% after the biopharmaceutical company raised $300 million in an upsized US initial public offering. The sha…
[IPO Concept with Stock Market Graphs] AlexSecret * Clinical-stage biopharmaceutical company Avalyn Pharma (AVLN [https://seekingalpha.com/symbol/AVLN]) priced [https://seekingalpha.com/pr/20493899-avalyn-announces-pricing-of-upsized-initi…
BOSTON, April 29, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN) (“Avalyn”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, tod…
aprott Avalyn Pharma (AVLN [https://seekingalpha.com/symbol/AVLN]), a biotech focused on developing inhaled therapeutics for the lung disorder pulmonary fibrosis, has filed paperwork with the SEC for its initial public offering in the U.S.…
(Bloomberg) -- Avalyn Pharma Inc., a biopharma company developing inhaled treatments for respiratory diseases, filed for a US initial public offering. The Boston-based company’s pipeline is focused on treating pulmonary fibrosis, a disease…
Dow Jones Futures: AppLovin, Nvidia, Palantir and Tesla sold off Monday during the stock market drop. Fed minutes are due Tuesday. Continue Reading